American Battery Materials, Inc.: American Battery Materials Announces Anticipated Uplisting to the NYSE American Stock Exchange

American Battery Materials Inc. (OTC: BLTH) said its common stock and warrants are expected to be approved for listing on NYSE American. It expects BLTH to start trading on or about July 24, 2026, and BLTH WS for warrants, subject to final approval and compliance. OTCID quotation is expected to end around July 23, 2026.

Original reporting
Published Jul 21, 2026, 11:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 21, 2026, 11:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$BLTH
Bullish
medium confidence
Mentioned
$BLTH
Relevance
6/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$BLTHBullishMed
01

Why it matters

The key tradable element is the venue change mechanics: expected approval, first trading symbols, and the OTCID quotation termination timing, which can affect spreads, volume, and short-term volatility.

02

Market read

This is a corporate actions and market-structure catalyst rather than an earnings or project update, making it most relevant for short-term liquidity and event-driven positioning.

03

What to watch

Final authorization and ongoing NYSE American compliance are gating items; any delay or conditions could cause a sell-the-news reaction or trading disruption during the OTCID termination window.

Relevance 6/10Novelty 6/10Timing: Ahead of the expected NYSE American open around July 24, 2026, after OTCID trading ends around July 23.

Background

The company is an OTC-listed critical-minerals/DLE developer and is moving its common stock and warrants to NYSE American.

Company-level read

Ticker impact

$BLTHBullishMedium confidence
Context

American Battery Materials says its common stock and warrants are expected to be approved for NYSE American listing under BLTH and BLTH WS around July 24, 2026.

Expected impact

Likely modest positive bias into the July 24 uplisting open, with volatility risk around final authorization and the OTC-to-NYSE transition.

Evidence & confidence

The article discloses a concrete corporate action timeline (expected listing approval and first trading date) but provides no financial metrics or guidance, limiting magnitude certainty.

Market effects

Could modestly improve sentiment toward DLE and critical-minerals microcaps by signaling continued capital-market access.

Primarily US market microstructure impact via OTC to NYSE American venue change.

Limited direct global read-through; impact is mostly on trading/liquidity rather than project fundamentals.

Counterpoint

Uplisting headlines may not translate into fundamentals; if liquidity gains are offset by dilution risk or weak demand, the stock may fade after the transition.

Key entities

  • American Battery Materials, Inc.

    OTC-listed company expected to uplist common stock to NYSE American under BLTH and warrants under BLTH WS around July 24, 2026.

  • NYSE American LLC

    Planned new listing venue for the company’s common stock and warrants, subject to final authorization and compliance.

Related articles

$RIOMed

Rio Tinto eyes $A7b capital release, iron ore sales up

Rio Tinto reported a 2% increase in Pilbara iron ore sales to 85.7 million tonnes, exceeding estimates. The company aims to release $7.2 billion in capital by 2026, with $2 billion already released this year. Copper output remained flat, and lithium production is expected at the lower end of forecasts. Iron ore sales for 2026 are forecasted between 323-338 million tonnes.

$SNYMed

Korea health agency lets Sanofi cut NIP flu supply, igniting favoritism furor

Sanofi-Aventis Korea reduced its National Immunization Program (NIP) flu vaccine supply from 2.25M to 1.75M doses due to production disruptions. The Korea Disease Control and Prevention Agency amended the contract without penalties, allowing Sanofi to divert 500,000 doses to the higher-priced private market. Critics argue this favors Sanofi and may disrupt supply for domestic firms like GCGC Biopharma (006280).

$GETYHighAI 8/10

Getty Images files for Bankruptcy

Getty Images (OTCPK: GETY) filed for Chapter 11 bankruptcy, delisting from the NYSE. The company secured a restructuring deal with Koch Equity Development and the Getty family, wiping out debt and going private. The move follows a failed merger with Shutterstock and declining subscriber numbers due to AI competition. Operations will continue as usual.

MedAI 8/10

Getty Images to keep Seattle HQ as it goes private through bankruptcy

Getty Images plans to keep its Seattle HQ and avoid layoffs as it goes private through bankruptcy to cut debt. The company reported $981M revenue and $84M operating income in 2023, but a $206M net loss. Getty's debt totals $1.5B, with a failed merger and AI competition impacting its business. Koch Equity Development will invest $533M. Trading was suspended after shares fell to 12 cents.